T-VEC, a GM-CSF expressing oncolytic herpes virus, has been shown not only to be efficacious in advanced melanoma, but also can increase tumor antigen-specific T cells and decrease regulatory T cells and MDSC [7,12]. The gene discussed is CSF2; the disease is neoplasm.